Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Bar

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Nature Communications|January 28, 2021
Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosisAvia Watson, Hao Li, Bingting Ma, et al.
Journal of Neurointerventional Surgery|November 18, 2017
Mechanical thrombectomy performs similarly in real world practice: a 2016 nationwide study from the Czech RepublicOndrej Volny, Antonin Krajina, Silvie Belaskova, et al.
Central European Journal of Public Health|April 26, 2024
The relationship between atherosclerosis and dementiaJana Janoutová, Ondřej Machaczka, Martina Kovalová, et al.
Central European Journal of Public Health|April 13, 2026
Atherosclerosis and dementia development: an epidemiological case-control studyVeronika Koutná, Ladislav Štěpánek, Martina Kovalová, et al.
British Journal of Haematology|January 21, 2017
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1Michal Bar-Natan, Dina Stroopinsky, Katarina Luptakova, et al.
Journal of Cellular and Molecular Medicine|May 16, 2018
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanismDina Stroopinsky, Hasan Rajabi, Myrna Nahas, et al.
Journal of the Peripheral Nervous System : JPNS|June 14, 2023
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trialVera Bril, Robert D M Hadden, Thomas H Brannagan, et al.
Blood Advances|September 28, 2021
PD-1 inhibition in advanced myeloproliferative neoplasmsGabriela Hobbs, Cansu Cimen Bozkus, Erin Moshier, et al.
Blood|July 7, 2021
Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signaturesAlberto Herrera, Anthony Cheng, Eleni P Mimitou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2013
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targetsSophia Adamia, Benjamin Haibe-Kains, Patrick M Pilarski, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Nature Communications|January 28, 2021
Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosisAvia Watson, Hao Li, Bingting Ma, et al.
Journal of Neurointerventional Surgery|November 18, 2017
Mechanical thrombectomy performs similarly in real world practice: a 2016 nationwide study from the Czech RepublicOndrej Volny, Antonin Krajina, Silvie Belaskova, et al.
Central European Journal of Public Health|April 26, 2024
The relationship between atherosclerosis and dementiaJana Janoutová, Ondřej Machaczka, Martina Kovalová, et al.
Central European Journal of Public Health|April 13, 2026
Atherosclerosis and dementia development: an epidemiological case-control studyVeronika Koutná, Ladislav Štěpánek, Martina Kovalová, et al.
British Journal of Haematology|January 21, 2017
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1Michal Bar-Natan, Dina Stroopinsky, Katarina Luptakova, et al.
Journal of Cellular and Molecular Medicine|May 16, 2018
MUC1-C drives myeloid leukaemogenesis and resistance to treatment by a survivin-mediated mechanismDina Stroopinsky, Hasan Rajabi, Myrna Nahas, et al.
Journal of the Peripheral Nervous System : JPNS|June 14, 2023
Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trialVera Bril, Robert D M Hadden, Thomas H Brannagan, et al.
Blood Advances|September 28, 2021
PD-1 inhibition in advanced myeloproliferative neoplasmsGabriela Hobbs, Cansu Cimen Bozkus, Erin Moshier, et al.
Blood|July 7, 2021
Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signaturesAlberto Herrera, Anthony Cheng, Eleni P Mimitou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2013
A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targetsSophia Adamia, Benjamin Haibe-Kains, Patrick M Pilarski, et al.
Pageof 11